IGF1 LR3 (Insulin-like Growth Factor 1 Long Arg3) is a synthetic analog of IGF1 , a hormone structurally similar to insulin that plays a central role in cell growth, repair, and muscle hypertrophy
Spending on glucagon-like peptide-1 receptor agonists among US adults, JAMA Network Open (2025) H.R.4818 treat and reduce obesity act of 2023, Congress.gov (2023) Anti-obesity drugs will not be covered by Medicare and Medicaid in 2026, American College of Gastroenterology (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
The promise of GLP-1R/GcgR co-agonism in the treatment of obesity was highlighted in studies exploring its effect in concert with leptin therapy
For benchwork, semaglutide is the reference agonist when you want to study GLP-1 receptor pharmacology in isolation
Alan Moses, board chair of the diaTribe Foundation, moderated the panel, which focused on raising awareness about hypoglycemiaan ever-present concern for people with type 1 diabetes